Simulating the Formation of the Local Galaxy Population

We simulate the formation and evolution of the local galaxy population starting from initial conditions with a smoothed linear density field which matches that derived from the IRAS 1.2 Jy galaxy survey. Our simulations track the formation and evolution of all dark matter haloes more massive than 10e+11 solar masses out to a distance of 8000 km/s from the Milky Way. We implement prescriptions similar to those of Kauffmann et al. (1999) to follow the assembly and evolution of the galaxies within these haloes. We focus on two variants of the CDM cosmology: an LCDM and a tCDM model. Galaxy formation in each is adjusted to reproduce the I-band Tully-Fisher relation of Giovanelli et al. (1997). We compare the present-day luminosity functions, colours, morphology and spatial distribution of our simulated galaxies with those of the real local population, in particular with the Updated Zwicky Catalog, with the IRAS PSCz redshift survey, and with individual local clusters such as Coma, Virgo and Perseus. We also use the simulations to study the clustering bias between the dark matter and galaxies of differing type. Although some significant discrepancies remain, our simulations recover the observed intrinsic properties and the observed spatial distribution of local galaxies reasonably well. They can thus be used to calibrate methods which use the observed local galaxy population to estimate the cosmic density parameter or to draw conclusions about the mechanisms of galaxy formation. To facilitate such work, we publically release our z=0 galaxy catalogues, together with the underlying mass distribution.Comment: 25 pages, 20 figures, submitted to MNRAS. High resolution copies of figures 1 and 3, halo and galaxy catalogues can be found at http://www.mpa-garching.mpg.de/NumCos/CR/index.htm

Detections of CO in Late-Type, Low Surface Brightness Spiral Galaxies

Using the IRAM 30-m telescope, we have obtained 12CO J=1-0 and 2-1 spectral line observations toward the nuclear regions of 15 edge-on, low surface brightness (LSB) spiral galaxies. Our sample comprises extreme late-type LSB spirals with disk-dominated morphologies and rotational velocities V_rot<~120 km/s. We report detections of four galaxies in at least one transition (>5sigma); for the remainder of the sample we provide upper limits on the nuclear CO content. Adopting a standard Galactic I_CO-to-H_2 conversion factor implies molecular gas masses of (3.3-9.8)x10**6 M_sun in the nuclear regions (inner 1.1-1.8 kpc) of the detected galaxies. Combining our new data with samples of late-type spirals from the literature, we find that the CO-detected LSB spirals adhere to the same M_H2-FIR correlation as more luminous and higher surface brightness galaxies. The amount of CO in the central regions of late-type spirals appears to depend more strongly on mass than on central optical surface brightness, and CO detectability declines significantly for moderate-to-low surface brightness spirals with V_rot<~90 km/s; no LSB spirals have so far been detected in CO below this threshold. Metallicity effects alone are unlikely to account for this trend, and we speculate that we are seeing the effects of a decrease in the mean fraction of a galaxy disk able to support giant molecular cloud formation with decreasing galaxy mass.Comment: accepted to A

CO emission and associated HI absorption from a massive gas reservoir surrounding the z=3 radio galaxy B3 J2330+3927

We present results of a comprehensive multi-frequency study of the radio galaxy B3 J2330+3927. The 1.9" wide radio source, consisting of 3 components, is bracketed by 2 objects in our Keck K-band image. Optical and near-IR Keck spectroscopy of these two objects yield z=3.087+-0.004. The brightest (K=18.8) object has a standard type II AGN spectrum, and is the most likely location of the AGN, which implies a one-sided jet radio morphology. Deep 113 GHz observations with the IRAM Plateau de Bure Interferometer reveal CO J=4-3 emission, which peaks at the position of the AGN. The CO line is offset by 500 km/s from the systemic redshift of the AGN, but corresponds very closely to the velocity shift of an associated HI absorber seen in Lya. This strongly suggests that both originate from the same gas reservoir surrounding the AGN host galaxy. Simultaneous 230 GHz interferometer observations find a ~3x lower integrated flux density when compared to single dish 250 GHz observations with MAMBO at the IRAM 30m telescope. This can be interpreted as spatially resolved thermal dust emission at scales of 0.5" to 6". Finally, we present a tau <1.3% limit to the HI 21 cm absorption against the radio source, which represents the seventh non-detection out of 8 z>2 radio galaxies observed to date with the WSRT. We present mass estimates for the atomic, neutral, and ionized hydrogen, and for the dust, ranging from M(HI)=2x10^7 M_Sun derived from the associated HI absorber in Lya up to M(H_2)=7x10^{10} M_Sun derived from the CO emission. This indicates that the host galaxy is surrounded by a massive reservoir of gas and dust. The K-band companion objects may be concentrations within this reservoir, which will eventually merge with the central galaxy hosting the AGN.Comment: 16 Pages, including 11 PostScript figures. Accepted for publication in Astronomy & Astrophysic

CMB Telescopes and Optical Systems

The cosmic microwave background radiation (CMB) is now firmly established as a fundamental and essential probe of the geometry, constituents, and birth of the Universe. The CMB is a potent observable because it can be measured with precision and accuracy. Just as importantly, theoretical models of the Universe can predict the characteristics of the CMB to high accuracy, and those predictions can be directly compared to observations. There are multiple aspects associated with making a precise measurement. In this review, we focus on optical components for the instrumentation used to measure the CMB polarization and temperature anisotropy. We begin with an overview of general considerations for CMB observations and discuss common concepts used in the community. We next consider a variety of alternatives available for a designer of a CMB telescope. Our discussion is guided by the ground and balloon-based instruments that have been implemented over the years. In the same vein, we compare the arc-minute resolution Atacama Cosmology Telescope (ACT) and the South Pole Telescope (SPT). CMB interferometers are presented briefly. We conclude with a comparison of the four CMB satellites, Relikt, COBE, WMAP, and Planck, to demonstrate a remarkable evolution in design, sensitivity, resolution, and complexity over the past thirty years.Comment: To appear in: Planets, Stars and Stellar Systems (PSSS), Volume 1: Telescopes and Instrumentatio

The EFSUMB Guidelines and Recommendations for Musculoskeletal Ultrasound - Part I: Extraarticular Pathologies

The first part of the guidelines and recommendations for musculoskeletal ultrasound, produced under the auspices of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB), provides information about the use of musculoskeletal ultrasound for assessing extraarticular structures (muscles, tendons, entheses, ligaments, bones, bursae, fasciae, nerves, skin, subcutaneous tissues, and nails) and their pathologies. Clinical applications, practical points, limitations, and artifacts are described and discussed for every structure. After an extensive literature review, the recommendations have been developed according to the Oxford Centre for Evidence-based Medicine and GRADE criteria and the consensus level was established through a Delphi process. The document is intended to guide clinical users in their daily practice

Development and implementation of guidelines for the management of depression: a systematic review

Objective: To evaluate the development and implementation of clinical practice guidelines for the management of depression globally. Methods: We conducted a systematic review of existing guidelines for the management of depression in adults with major depressive or bipolar disorder. For each identified guideline, we assessed compliance with measures of guideline development quality (such as transparency in guideline development processes and funding, multidisciplinary author group composition, systematic review of comparative efficacy research) and implementation (such as quality indicators). We compared guidelines from low- and middle-income countries with those from high-income countries. Findings: We identified 82 national and 13 international clinical practice guidelines from 83 countries in 27 languages. Guideline development processes and funding sources were explicitly specified in a smaller proportion of guidelines from low- and middle-income countries (8/29; 28%) relative to high-income countries (35/58; 60%). Fewer guidelines (2/29; 7%) from low- and middle-income countries, relative to high-income countries (22/58; 38%), were authored by a multidisciplinary development group. A systematic review of comparative effectiveness was conducted in 31% (9/29) of low- and middle-income country guidelines versus 71% (41/58) of high-income country guidelines. Only 10% (3/29) of low- and middle-income country and 19% (11/58) of high-income country guidelines described plans to assess quality indicators or recommendation adherence. Conclusion: Globally, guideline implementation is inadequately planned, reported and measured. Narrowing disparities in the development and implementation of guidelines in low- and middle-income countries is a priority. Future guidelines should present strategies to implement recommendations and measure feasibility, cost-effectiveness and impact on health outcomes

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry

OBJECTIVES: The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). METHODS: The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcer disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to digital ulcers. RESULTS: Up to 19 November 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (lcSSc; 52.2%) or diffuse cutaneous SSc (dcSSc; 36.9%). Digital ulcers developed earlier in patients with dcSSc compared with lcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45.2% for anti-scleroderma-70 and 43.6% for anticentromere antibodies (ACA). The first digital ulcer in the anti-scleroderma-70-positive patient cohort occurred approximately 5 years earlier than the ACA-positive patient group. CONCLUSIONS: This study provides data from a large cohort of SSc patients with a history of digital ulcers. The early occurrence and high frequency of digital ulcer complications are especially seen in patients with dcSSc and/or anti-scleroderma-70 antibodies